US11732251B2ActiveUtilityA1
Anti-CRISPR polynucleotides and polypeptides and methods of use
Est. expiryApr 24, 2037(~10.8 yrs left)· nominal 20-yr term from priority
Inventors:Christophe FremauxPhilippe HorvathAlexander HynesMarie-Laurence LemaySylvain MoineauDennis RomeroGeneviève RousseauJoshua K. Young
C12N 9/22C07K 14/005C07K 14/315C12N 15/63C12N 2795/10322
51
PatentIndex Score
0
Cited by
165
References
4
Claims
Abstract
Methods and compositions are provided for the use of anti-CRISPR (ACR) proteins in plants, including modulation of Cas endonuclease activity, improvement of frequency of homologous recombination, control of Cas endonuclease activity during various cell cycles, spatial and/or temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, as well as reduction of off-target polynucleotide cleavage.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method for modulating the activity of a Cas endonuclease with a target polynucleotide in a cell, comprising providing an anti-CRISPR (ACR) polypeptide having an amino acid sequence at least 90% identical to SEQ ID NO:8 to the cell, wherein the ACR polypeptide decreases the activity of the Cas endonuclease in the cell compared to a control cell comprising the Cas endonuclease but not comprising the ACR polypeptide.
2. The method of claim 1 , wherein the Cas endonuclease activity is selected from the group consisting of target polynucleotide binding, target polynucleotide nicking, target polynucleotide double-strand-break creation, and target polynucleotide modification.
3. The method of claim 2 , wherein said target polynucleotide modification is selected from the group consisting of insertion of at least one nucleotide, deletion of at least one nucleotide, substitution of at least one nucleotide, and chemical alteration of at least one nucleotide.
4. The method of claim 1 , wherein the cell is selected from the group consisting of a plant cell, an animal cell, a mammalian cell, a microbial cell and a fungal cell.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.